Table of Content

1 Market Overview of Cancer Immunotherapy
1.1 Cancer Immunotherapy Market Overview
1.1.1 Cancer Immunotherapy Product Scope
1.1.2 Cancer Immunotherapy Market Status and Outlook
1.2 Global Cancer Immunotherapy Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Cancer Immunotherapy Market Size by Region (2024-2034)
1.4 Global Cancer Immunotherapy Historic Market Size by Region (2024-2024)
1.5 Global Cancer Immunotherapy Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Cancer Immunotherapy Market Size (2024-2034)
1.6.1 North America Cancer Immunotherapy Market Size (2024-2034)
1.6.2 Europe Cancer Immunotherapy Market Size (2024-2034)
1.6.3 Asia-Pacific Cancer Immunotherapy Market Size (2024-2034)
1.6.4 Latin America Cancer Immunotherapy Market Size (2024-2034)
1.6.5 Middle East & Africa Cancer Immunotherapy Market Size (2024-2034)
2 Cancer Immunotherapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Immune Checkpoint Inhibitors
2.1.3 Immune System Modulators
2.1.4 Cancer Vaccines
2.2 Global Cancer Immunotherapy Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Cancer Immunotherapy Historic Market Size by Type (2024-2024)
2.2.2 Global Cancer Immunotherapy Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Cancer Immunotherapy Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Cancer Immunotherapy Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Cancer Immunotherapy Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Cancer Immunotherapy Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Cancer Immunotherapy Revenue Breakdown by Type (2024-2034)
3 Cancer Immunotherapy Market Overview by Application
3.1 Introduction
3.1.1 Lung Cancer
3.1.2 Breast Cancer
3.1.3 Colorectal Cancer
3.1.4 Melanoma
3.1.5 Prostate Cancer
3.1.6 Others
3.2 Global Cancer Immunotherapy Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Cancer Immunotherapy Historic Market Size by Application (2024-2024)
3.2.2 Global Cancer Immunotherapy Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Cancer Immunotherapy Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Cancer Immunotherapy Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Cancer Immunotherapy Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Cancer Immunotherapy Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Cancer Immunotherapy Revenue Breakdown by Application (2024-2034)
4 Cancer Immunotherapy Competition Analysis by Players
4.1 Global Cancer Immunotherapy Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2022)
4.3 Date of Key Players Enter into Cancer Immunotherapy Market
4.4 Global Top Players Cancer Immunotherapy Headquarters and Area Served
4.5 Key Players Cancer Immunotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 Cancer Immunotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Cancer Immunotherapy Products, Services and Solutions
5.1.4 Amgen Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.1.5 Amgen Recent Developments
5.2 AstraZeneca
5.2.1 AstraZeneca Profile
5.2.2 AstraZeneca Main Business
5.2.3 AstraZeneca Cancer Immunotherapy Products, Services and Solutions
5.2.4 AstraZeneca Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.2.5 AstraZeneca Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Cancer Immunotherapy Products, Services and Solutions
5.3.4 Roche Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Cancer Immunotherapy Products, Services and Solutions
5.4.4 Bayer Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.4.5 Bayer Recent Developments
5.5 Bristol-Myers Squibb
5.5.1 Bristol-Myers Squibb Profile
5.5.2 Bristol-Myers Squibb Main Business
5.5.3 Bristol-Myers Squibb Cancer Immunotherapy Products, Services and Solutions
5.5.4 Bristol-Myers Squibb Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.5.5 Bristol-Myers Squibb Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly Cancer Immunotherapy Products, Services and Solutions
5.6.4 Eli Lilly Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.6.5 Eli Lilly Recent Developments
5.7 Merck
5.7.1 Merck Profile
5.7.2 Merck Main Business
5.7.3 Merck Cancer Immunotherapy Products, Services and Solutions
5.7.4 Merck Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.7.5 Merck Recent Developments
5.8 Novartis
5.8.1 Novartis Profile
5.8.2 Novartis Main Business
5.8.3 Novartis Cancer Immunotherapy Products, Services and Solutions
5.8.4 Novartis Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.8.5 Novartis Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Cancer Immunotherapy Products, Services and Solutions
5.9.4 Pfizer Cancer Immunotherapy Revenue (US$ Million) & (2024-2024)
5.9.5 Pfizer Recent Developments
6 North America
6.1 North America Cancer Immunotherapy Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cancer Immunotherapy Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cancer Immunotherapy Market Dynamics
11.1 Cancer Immunotherapy Industry Trends
11.2 Cancer Immunotherapy Market Drivers
11.3 Cancer Immunotherapy Market Challenges
11.4 Cancer Immunotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Cancer Immunotherapy Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Cancer Immunotherapy Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Cancer Immunotherapy Market Size Share by Region (2024-2024)
Table 4. Global Cancer Immunotherapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Cancer Immunotherapy Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Cancer Immunotherapy Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Cancer Immunotherapy Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Cancer Immunotherapy Revenue Market Share by Type (2024-2024)
Table 9. Global Cancer Immunotherapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Table 11. North America Cancer Immunotherapy Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Cancer Immunotherapy Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Cancer Immunotherapy Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Cancer Immunotherapy Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Cancer Immunotherapy Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Cancer Immunotherapy Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Cancer Immunotherapy Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Cancer Immunotherapy Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Cancer Immunotherapy Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Cancer Immunotherapy Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Cancer Immunotherapy Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Cancer Immunotherapy Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Cancer Immunotherapy Revenue Market Share by Application (2024-2024)
Table 24. Global Cancer Immunotherapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Table 26. North America Cancer Immunotherapy Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Cancer Immunotherapy Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Cancer Immunotherapy Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Cancer Immunotherapy Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Cancer Immunotherapy Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Cancer Immunotherapy Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Cancer Immunotherapy Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Cancer Immunotherapy Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Cancer Immunotherapy Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Cancer Immunotherapy Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Cancer Immunotherapy Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Cancer Immunotherapy Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2022)
Table 39. Date of Key Players Enter into Cancer Immunotherapy Market
Table 40. Global Cancer Immunotherapy Key Players Headquarters and Area Served
Table 41. Cancer Immunotherapy Product Solution and Service
Table 42. Global Cancer Immunotherapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Amgen Basic Information List
Table 45. Amgen Description and Business Overview
Table 46. Amgen Cancer Immunotherapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Cancer Immunotherapy Business of Amgen (2024-2024)
Table 48. Amgen Recent Developments
Table 49. AstraZeneca Basic Information List
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Cancer Immunotherapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Cancer Immunotherapy Business of AstraZeneca (2024-2024)
Table 53. AstraZeneca Recent Developments
Table 54. Roche Basic Information List
Table 55. Roche Description and Business Overview
Table 56. Roche Cancer Immunotherapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Cancer Immunotherapy Business of Roche (2024-2024)
Table 58. Roche Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer Cancer Immunotherapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Cancer Immunotherapy Business of Bayer (2024-2024)
Table 63. Bayer Recent Developments
Table 64. Bristol-Myers Squibb Basic Information List
Table 65. Bristol-Myers Squibb Description and Business Overview
Table 66. Bristol-Myers Squibb Cancer Immunotherapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Cancer Immunotherapy Business of Bristol-Myers Squibb (2024-2024)
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. Eli Lilly Basic Information List
Table 70. Eli Lilly Description and Business Overview
Table 71. Eli Lilly Cancer Immunotherapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Cancer Immunotherapy Business of Eli Lilly (2024-2024)
Table 73. Eli Lilly Recent Developments
Table 74. Merck Basic Information List
Table 75. Merck Description and Business Overview
Table 76. Merck Cancer Immunotherapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Cancer Immunotherapy Business of Merck (2024-2024)
Table 78. Merck Recent Developments
Table 79. Novartis Basic Information List
Table 80. Novartis Description and Business Overview
Table 81. Novartis Cancer Immunotherapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Cancer Immunotherapy Business of Novartis (2024-2024)
Table 83. Novartis Recent Developments
Table 84. Pfizer Basic Information List
Table 85. Pfizer Description and Business Overview
Table 86. Pfizer Cancer Immunotherapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Cancer Immunotherapy Business of Pfizer (2024-2024)
Table 88. Pfizer Recent Developments
Table 89. North America Cancer Immunotherapy Market Size by Country (2024-2024) & (US$ Million)
Table 90. North America Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 91. Europe Cancer Immunotherapy Market Size by Country (2024-2024) & (US$ Million)
Table 92. Europe Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Cancer Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 94. Asia-Pacific Cancer Immunotherapy Market Size by Region (2024-2024) & (US$ Million)
Table 95. Asia-Pacific Cancer Immunotherapy Market Size by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Cancer Immunotherapy Market Share by Region (2024-2024)
Table 97. Asia-Pacific Cancer Immunotherapy Market Share by Region (2024-2034)
Table 98. Latin America Cancer Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Latin America Cancer Immunotherapy Market Size by Country (2024-2024) & (US$ Million)
Table 100. Latin America Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 101. Middle East & Africa Cancer Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 102. Middle East & Africa Cancer Immunotherapy Market Size by Country (2024-2024) & (US$ Million)
Table 103. Middle East & Africa Cancer Immunotherapy Market Size by Country (2024-2034) & (US$ Million)
Table 104. Cancer Immunotherapy Market Trends
Table 105. Cancer Immunotherapy Market Drivers
Table 106. Cancer Immunotherapy Market Challenges
Table 107. Cancer Immunotherapy Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Immunotherapy Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Cancer Immunotherapy Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Cancer Immunotherapy Market Share by Regions: 2022 VS 2034
Figure 4. Global Cancer Immunotherapy Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Cancer Immunotherapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Cancer Immunotherapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Cancer Immunotherapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Cancer Immunotherapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Cancer Immunotherapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Monoclonal Antibodies
Figure 11. Global Monoclonal Antibodies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Immune Checkpoint Inhibitors
Figure 13. Global Immune Checkpoint Inhibitors Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Immune System Modulators
Figure 15. Global Immune System Modulators Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Cancer Vaccines
Figure 17. Global Cancer Vaccines Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Cancer Immunotherapy Market Size Share by Type: 2022 & 2034
Figure 19. North America Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Figure 20. Europe Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Cancer Immunotherapy Revenue Market Share by Type (2024-2034)
Figure 24. Lung Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Breast Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Melanoma Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Prostate Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 29. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 30. Global Cancer Immunotherapy Market Size Share by Application: 2022 & 2034
Figure 31. North America Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Figure 32. Europe Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Figure 33. Asia-Pacific Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Figure 34. Latin America Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Figure 35. Middle East and Africa Cancer Immunotherapy Revenue Market Share by Application (2024-2034)
Figure 36. Cancer Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 37. Global Top 5 and Top 10 Players Cancer Immunotherapy Market Share in 2022
Figure 38. North America Cancer Immunotherapy Market Share by Country (2024-2034)
Figure 39. U.S. Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 40. Canada Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 41. Germany Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 42. France Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 43. U.K. Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 44. Italy Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 45. Russia Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 46. Nordic Countries Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 47. Asia-Pacific Cancer Immunotherapy Market Share by Region (2024-2034)
Figure 48. China Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 49. Japan Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 50. South Korea Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 51. Southeast Asia Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 52. India Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 53. Australia Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 54. Latin America Cancer Immunotherapy Market Share by Country (2024-2034)
Figure 55. Mexico Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 56. Brazil Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 57. Middle East & Africa Cancer Immunotherapy Market Share by Country (2024-2034)
Figure 58. Turkey Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 59. Saudi Arabia Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 60. UAE Cancer Immunotherapy Market Size (2024-2034) & (US$ Million)
Figure 61. Bottom-up and Top-down Approaches for This Report